Routine Invasive Management After Fibrinolysis in STEMI Patients
Author Information
Author(s): Bogaty Peter, Filion Kristian B, Brophy James M
Primary Institution: Institut universitaire de cardiologie et pneumologie de Québec
Hypothesis
Is routine invasive management after fibrinolysis beneficial for patients with ST-elevation myocardial infarction compared to standard care?
Conclusion
Definitive evidence supporting routine invasive management following fibrinolysis in STEMI patients is currently lacking due to significant methodological limitations.
Supporting Evidence
- Nine randomized clinical trials were reviewed, all suggesting a benefit from routine early invasive management.
- Important design variations precluded a formal quantitative meta-analysis.
- Several trials did not compare routine invasive management with a selective approach.
Takeaway
This study looked at whether patients who get a certain heart treatment after a blood clot can do better than those who get regular care. It found that we still don't know for sure if one way is better than the other.
Methodology
The study systematically reviewed randomized clinical trials comparing routine invasive management after fibrinolysis with standard care.
Potential Biases
Potential biases include asymmetric use of anti-platelet agents and differences in definitions of reinfarction.
Limitations
The study faced important methodological limitations, including variations in trial designs and the lack of consistent endpoints.
Participant Demographics
The trials included a total of 3320 patients with ST-elevation myocardial infarction.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.36-1.16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website